NIH, Columbia Team Employs Drug and Gene Screens to Find Antimalarial Candidates
August 04, 2011
NIH, Columbia Team Employs Drug and Gene Screens to Find Antimalarial Candidates
Researchers from the National Institutes of Health and Columbia University screened more than 2,800 compounds in 61 Plasmodium falciparum lines, identifying potential anti-malarial agents and using genetic approaches to find loci related to treatment response differences in the malaria parasite.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Antigen Discovery Lands $2.5M SBIR Grant to Develop CDx for Sanaria's Malaria Products
August 13, 2012 / GenomeWeb Daily News - Multi-institutional GWAS IDs Variant to Improve Warfarin Dosing in People of African Descent
June 12, 2013 / Pharmacogenomics Reporter - Two New Studies Uncover a Dozen New Testicular Cancer Risk Loci
May 14, 2013 / GenomeWeb Daily News - Genomics in the Journals
May 2, 2013 / GenomeWeb Daily News - Large-Scale Metabochip Studies ID New Susceptibility Loci for Glycemic Traits and Diabetes
August 28, 2012 / BioArray News